Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 5, 2024
Abstract
Type
2
diabetes
(T2D)
is
a
risk
factor
for
mucosal
homeostasis
and
enhances
the
susceptibility
to
inflammation,
in
which
neutrophils
have
been
increasingly
appreciated
their
role.
Here,
barrier
disruption
inflammation
are
observed
at
oral
mucosa
(gingiva)
of
T2D
patients
mice.
It
demonstrated
that
infiltrate
gingival
mice
expel
obvious
neutrophil
extracellular
traps
(NETs),
while
removal
NETs
alleviates
barrier.
Mechanistically,
released
dependent
metabolic
reprogramming.
Under
hyperglycemic
condition,
elevate
both
glucose
incorporation
glycolysis
via
increased
expression
GLUT1.
Moreover,
significantly
levels
local
lesions
patients,
associated
with
clinical
disease
severity.
This
work
elucidates
causative
link
between
hyperglycemia
immunopathology,
mediated
by
altered
immuno‐metabolic
axis
neutrophil,
thereby
suggesting
potential
therapeutic
strategy.
Aggregate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 6, 2024
Abstract
Diabetes
significantly
impairs
the
body's
wound‐healing
capabilities,
leading
to
chronic,
infection‐prone
wounds.
These
wounds
are
characterized
by
hyperglycemia,
inflammation,
hypoxia,
variable
pH
levels,
increased
matrix
metalloproteinase
activity,
oxidative
stress,
and
bacterial
colonization.
complex
conditions
complicate
effective
wound
management,
prompting
development
of
advanced
diabetic
care
strategies
that
exploit
specific
characteristics
such
as
acidic
pH,
high
glucose
stress
trigger
controlled
drug
release,
thereby
enhancing
therapeutic
effects
dressings.
Among
solutions,
hydrogels
emerge
promising
due
their
stimuli‐responsive
nature,
making
them
highly
for
managing
these
The
latest
advancements
in
mono/multi‐stimuli‐responsive
smart
showcase
superiority
potential
healthcare
materials,
highlighted
relevant
case
studies.
However,
traditional
dressings
fall
short
meeting
nuanced
needs
wounds,
adjustable
adhesion,
easy
removal,
real‐time
status
monitoring,
dynamic
release
adjustment
according
wound's
conditions.
Responsive
represent
a
significant
leap
forward
proficient
sensing
responding
environment,
offering
more
targeted
approach
treatment.
This
review
highlights
recent
dressing,
delivery,
emphasizing
role
improving
healing.
It
addresses
ongoing
challenges
future
directions,
aiming
guide
clinical
adoption.
Diabetic
Kidney
Disease
(DKD)
is
a
common
complication
of
Type
2
Diabetes
Mellitus
and
major
risk
factor
for
end-stage
kidney
disease.
The
immune
system
plays
significant
role
in
the
pathogenesis
DKD,
involving
infiltration
cells
kidney,
upregulation
in-flammatory
mediators,
downregulation
anti-inflammatory
disturbance
ad-hesion
molecules
growth
factors.
Dendritic
are
professional
antigen-presenting
acting
as
bridge
connecting
innate
adaptive
responses.
DC
also
capable
modulating
inflammation.
Autologous
dendritic
can
be
made
by
vitro
differentiation
peripheral
blood
monocytes
then
utilized
cell-based
therapy.
Cell-based
therapy
DKD
currently
focused
on
utilizing
properties
stem
cells.
However,
research
suggests
unsatisfactory
results
due
to
several
limitations.
This
article
highlights
possibility
using
through
its
controlling
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 29, 2024
Neutrophils,
the
most
abundant
leukocytes
in
human
peripheral
circulation,
are
crucial
for
innate
immune
response.
They
typically
quiescent
but
rapidly
activate
response
to
infection
and
inflammation,
performing
diverse
functions
such
as
oxidative
burst,
phagocytosis,
NETosis,
which
require
significant
metabolic
adaptation.
Deeper
insights
into
changes
will
help
identify
regulation
of
neutrophil
health
diseases.
Due
their
short
lifespan
associated
technical
challenges,
processes
neutrophils
not
completely
understood.
This
study
uses
optical
imaging
(OMI),
entails
redox
ratio
fluorescence
lifetime
microscopy
intrinsic
coenzymes
NAD(P)H
FAD
assess
state
single
neutrophils.
Primary
were
imaged
Cellular and Molecular Life Sciences,
Journal Year:
2024,
Volume and Issue:
81(1)
Published: March 19, 2024
Abstract
Complications
associated
with
Type
1
and
2
diabetes,
such
as
diabetic
peripheral
neuropathy
foot
ulcers,
are
a
growing
health-care
concern.
In
addition,
this
concern
increases
patients
age
due
to
their
increased
susceptibility
complications.
To
address
problem,
it
is
important
understand
fluctuations
in
physiology
which
lead
pathological
changes
the
metabolic
disturbances
of
diabetes.
Our
study
explores
dysregulation
immune
cell
populations
hindpaws
healthy
mice
at
12
21
weeks
using
single-cell
RNA
sequencing
provide
insight
into
disruptions
occurring
distal
limb
during
chronic
21-week-old
Lepr
db/db
mice,
were
seen
mast
cells/basophils,
dermal
γδ
T
cells,
heterogeneous
innate
lymphoid
cells.
macrophages
represented
largest
cluster
cells
showed
greatest
increase
genes
immune-specific
pathways.
Sub-clustering
revealed
bias
toward
angiogenic
Lyve1
+
MHCII
lo
corresponded
an
on
histology.
results
show
that
immunological
function
phenotype
multiple
types
shift
not
only
disturbance,
but
also
duration
disease,
may
explain
pathologies
more
Immunity Inflammation and Disease,
Journal Year:
2025,
Volume and Issue:
13(2)
Published: Jan. 31, 2025
Chronic
wounds
are
a
severe
complication
of
diabetes.
Dysregulated
inflammatory
signalling
is
thought
to
underly
the
poor
healing
outcomes.
Yet,
there
little
information
available
on
acute
response
following
injury
and
its
impact
healing.
Using
murine
full
thickness
excisional
wound
model,
current
study
therefore
assessed
expression
pro-inflammatory
pro-resolving
lipid
mediators
during
early
stages
post
in
diabetic
compared
timeframe
for
transitioning
through
phases
Tissue
eicosanoid
(LTB4,
PGE2,
TxA2,
MaR1,
RvE1,
RvD1,
PD)
MMP-9
levels
were
at
6
h
wounding
using
ELISAs.
Wound
closure,
dynamics
(histology),
cellular
infiltration
MPO,
TNF-α
(IHC)
h,
day2,
day7
wounding.
Eicosanoid
did
not
differ
between
groups
(LTB4
24-125
pg/mL,
PGE2
63-177
TxA2
529-1184
MaR1
365-2052
RvE1
43-1157
RvD1
1.5-69
PD1
11.5-4.9
ng/mL).
An
inverse
relationship
(p
<
0.05)
eicosanoids
however
only
evident
wounds.
Diminished
(x5
fold)
coincided
with
significant
delay
(pro-inflammatory
cytokine)
MPO
(neutrophil
marker).
A
difference
(C
1.8
±
0.6;
DM
0.7
0.1
MFI)
4.9
1.9;
0.9
0.4
was
observed
as
wounding,
histology
parameters
supporting
notion
that
onset
delayed
These
observations
imply
immune
cells
unresponsive
initial
tissue.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 25, 2025
This
research
aims
to
design
and
validate
a
machine
learning
model
predict
the
probability
of
urinary
tract
infections
within
90
days
post-urostomy
in
bladder
cancer
patients.
Clinical
follow-up
information
from
317
patients
who
had
urostomy
procedures
at
First
Affiliated
Hospital
Shanxi
Medical
University
(May
2018–May
2024)
were
analyzed.
The
dataset
partitioned
into
training
testing
sets,
feature
selection
was
executed
via
Least
Absolute
Shrinkage
Selection
Operator
regression
technique.
Seven
algorithms
employed:
Logistic
Regression,
K-Nearest
Neighbors,
LightGBM,
Random
Forest,
XGBoost,
Support
Vector
Machine,
Multi-Layer
Perceptron.
Performance
metrics
for
assessed
using
multiple
evaluation
indicators,
including
AUC,
accuracy,
sensitivity,
specificity,
Positive
Predictive
Value,
Negative
F1
score.
SHapley
Additive
exPlanations
Local
Interpretable
Model-agnostic
Explanations
applied
interpretability.
UTIs
occurred
22.08%
after
urostomy.
predictive
pinpointed
eight
important
clinical
features.
Among
developed
models,
SVM
demonstrated
best
overall
performance
with
AUC
(0.835),
accuracy
(0.825),
precision
(0.583),
recall
(0.778),
score
(0.667).
model,
designed
assess
risk
patients,
has
been
deployed
online
healthcare
professionals
at:
https://zqmodel.shinyapps.io/shinydashboard_model/
.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 27, 2025
Sepsis
patients
with
diabetes
are
at
a
high
clinical
risk.
It
is
well
reported
that
XueBiJing
injection
has
good
benefit
in
sepsis
individuals.
However,
there
no
relevant
report
about
the
efficacy
and
safety
of
XBJ
comorbid
diabetes.
Data
two
large
randomized
controlled
trials
(XBJ-SAP
(ChiCTR-TRC-13003534)
EXIT-SEP
(NCT0323874))
were
combined,
post
hoc
analyses
performed.
further
divided
into
XBJ-treated
group
placebo
based
on
inclusion
exclusion
criteria.
The
primary
(28-day
mortality)
secondary
outcomes
(mortality
ICU
post-randomization
hospital,
acute
physiology,
chronic
health
evaluation
II
(APACHE
II)
score
sequential
organ
failure
assessment
(SOFA)
score)
compared
between
treatment
groups
status
baseline.
Moreover,
occurrence
adverse
events
(AEs)
was
also
assessed.
At
study
baseline,
total
378
(227
men
[60.0%]
151
women
[40.0%];
mean
[SD]
age,
60.3
[11.1]
years)
considered
to
have
diabetes,
which
177
received
201
administration.
Among
these
mortality
28
days
significantly
lower
than
(29
173
[16.8%]
vs.
56
198
[28.3%],
P
=
0.01),
absolute
risk
difference
11.5%
(95%
CI,
3.1%-19.9%).
Furthermore,
overall
incidence
when
used
(24.4%
[42
172
patients]
27.7%
[54
195
patients].
present
underscores
pivotal
role
modulating
immune
response
among
suffering
from
mellitus,
exploring
positive
effects
mellitus.
those
consistent
trial
findings,
demonstrating
efficacious
suggesting
need
for
special
precautions.
ChiCTR-TRC-13003534
NCT0323874.